Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CTSD | P07339 | 3/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8853761 | 0.87 | CA2 (0.66) | CA2CTSD | |
| SCHEMBL6447454 | 0.87 | CA2 (0.66) | CA2CTSD | |
| SCHEMBL29648527 | 0.87 | CA2 (0.66) | CA2CTSD | |
| SCHEMBL5805400 | 0.83 | PYGL (0.57) | PSMB5HTTKDM4ESMN1; SMN2CA2 | |
| SCHEMBL21623659 | 0.81 | PSMB5 (0.62) | PSMB5HTTKDM4ESMN1; SMN2CA2 | |
| SCHEMBL9554481 | 0.81 | PSMB5 (0.62) | PSMB5HTTKDM4ESMN1; SMN2CA2 | |
| SCHEMBL24862890 | 0.79 | CAPN1 (0.56) | PSMB5HTTKDM4ESMN1; SMN2MAPT | |
| SCHEMBL6931878 | 0.79 | CTRB1 (0.59) | PSMB5 | |
| SCHEMBL6448868 | 0.78 | ROCK2 (0.56) | HTTKDM4EMAPTEPHX2TDP1 | |
| SCHEMBL8013304 | 0.78 | PSMB5 (0.59) | PSMB5USP30 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0839798-A2 | Intermediates for preparating non-peptide retroviral protease inhibitors | ABBOTT LABORATORIES (US) | 1998-05-06 | — | — | EP | disclosed |
| US-5670675-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1997-09-23 | — | — | US | disclosed |
| US-5545750-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS | ABBOTT LABORATORIES (US) | 1996-08-13 | — | — | US | disclosed |
| US-5142056-A | Human immunodeficiency virus protease inhibitor | ABBOTT LABORATORIES (US) | 1992-08-25 | — | — | US | disclosed |
| EP-0402646-A1 | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1990-12-19 | — | — | EP | disclosed |